.png){kind=icon}
返回
Optogenetic Peripheral Nerve Immunogenicity
.png){kind=icon}
OA
AI
DOI：10.1038/s41598-018-32075-0.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Optogenetic technologies have been the subject of great excitement within the scientific community for their ability to demystify complex neurophysiological pathways in the central (CNS) and peripheral nervous systems (PNS). The excitement surrounding optogenetics has also extended to the clinic with a trial for ChR2 in the treatment of retinitis pigmentosa currently underway and additional trials anticipated for the near future. In this work, we identify the cause of loss-of-expression in response to transdermal illumination of an optogenetically active peroneal nerve following an anterior compartment (AC) injection of AAV6-hSyn-ChR2(H134R) with and without a fluorescent reporter. Using Sprague Dawley Rag2(-/-) rats and appropriate controls, we discover optogenetic loss-of-expression is chiefly elicited by ChR2-mediated immunogenicity in the spinal cord, resulting in both CNS motor neuron death and ipsilateral muscle atrophy in both low and high Adeno-Associated Virus (AAV) dosages. We further employ pharmacological immunosuppression using a slow-release tacrolimus pellet to demonstrate sustained transdermal optogenetic expression up to 12 weeks. These results suggest that all dosages of AAV-mediated optogenetic expression within the PNS may be unsafe. Clinical optogenetics for both PNS and CNS applications should take extreme caution when employing opsins to treat disease and may require concurrent immunosuppression. Future work in optogenetics should focus on designing opsins with lesser immunogenicity.
Keyword:
RECOMBINANT ADENOASSOCIATED VIRUS
GREEN FLUORESCENT PROTEIN
MEDIATED GENE-EXPRESSION
IMMUNE-RESPONSES
AAV VECTORS
SPINAL-CORD
IN-VITRO
CHANNELRHODOPSIN-2
PHOTOTOXICITY
HALORHODOPSIN
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.9
论文数:
28.3W
被引数:
83.5W
机构
引用论文
分享收藏Rapid and Efficient Clearance of Blood-borne Virus by Liver Sinusoidal Endothelium.png)
PLOS PATHOGENSOAAI
PLOS PATHOGENSIF4.9
OAAI分享收藏A histone deacetylase inhibitor enhances recombinant adeno-associated virus-mediated gene expression in tumor cells组蛋白去乙酰化酶抑制剂增强肿瘤细胞中重组腺相关病毒介导的基因表达OAAI
OAAI分享收藏
查看更多内容